These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
652 related articles for article (PubMed ID: 19530907)
1. Oral delivery of siRNA and antisense oligonucleotides. Akhtar S J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907 [TBL] [Abstract][Full Text] [Related]
2. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S; Benter I Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774 [TBL] [Abstract][Full Text] [Related]
3. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Fattal E; Bochot A Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528 [TBL] [Abstract][Full Text] [Related]
4. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA. de Martimprey H; Vauthier C; Malvy C; Couvreur P Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435 [TBL] [Abstract][Full Text] [Related]
5. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Fattal E; Bochot A Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190 [TBL] [Abstract][Full Text] [Related]
7. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides. Senn C; Hangartner C; Moes S; Guerini D; Hofbauer KG Eur J Pharmacol; 2005 Oct; 522(1-3):30-7. PubMed ID: 16213482 [TBL] [Abstract][Full Text] [Related]
8. Barriers to successful delivery of short interfering RNA after systemic administration. White PJ Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190 [TBL] [Abstract][Full Text] [Related]
17. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery. Singh SK; Hajeri PB Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929 [TBL] [Abstract][Full Text] [Related]
18. Chemical modification of gene silencing oligonucleotides for drug discovery and development. Chen X; Dudgeon N; Shen L; Wang JH Drug Discov Today; 2005 Apr; 10(8):587-93. PubMed ID: 15837602 [TBL] [Abstract][Full Text] [Related]
19. siRNA delivery systems for cancer treatment. Oh YK; Park TG Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869 [TBL] [Abstract][Full Text] [Related]
20. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. Gary DJ; Puri N; Won YY J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]